Pazopanib Hydrochloride

CAS: 635702-64-6

Ref. TM-T6930

Produktinformation

• Name: Pazopanib Hydrochloride
• Synonyme: GW786034, Pazopanib HCl, GW786034 HCl, Votrient HCl, Armala, 5-((4-((2,3-Dimethyl-2H-indazol-6-yl)methylamino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide monohydrochloride, 5-(4-((2,3-dimethyl-2H-indazol-6-yl)(Methyl)amino)pyrimidin-2-ylamino)-2-Methylbenzenesulfonamide hydrochloride, 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide hydrochloride, Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-,monohydrochloride, Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-, hydrochloride (1:1), Gw 786034B, Gw786034B, Pazopanib HCl, Unii-33Y9Anm545, Votrient
• CAS: 635702-64-6

Beschreibung

Pazopanib Hydrochloride (Votrient HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM in cell-free assays, respectively.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 473.98
• Formel: C₂₁H₂₃N₇O₂S·HCl
• Reinheit: 99.69%
• Farbe/Form: Solid